Qushi Tongluo decoction combined with azithromycin in the treatment of Mycoplasma pneumoniae pneumonia in children: a randomized, double-blind, single simulation, placebo-controlled, multicenter clinical trial

Affiliated Hospital of Shandong University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Patients who meet the diagnostic criteria of Western medicine for Mycoplasma pneumoniae pneumonia in children;
•2. Patients who meet the diagnostic criteria of damp heat obstructing lung syndrome;
•3. Hospitalized children aged 1-12 years;
•4. Patients with pneumonia within 48 hours of diagnosis;
•5. For those subjects whose informed consent process meets the requirements, the legal representative should sign the informed consent form (>= 8 years old children should sign the informed consent form at the same time).

•1. Patients with severe Mycoplasma pneumoniae pneumonia;
•2. Patients with obvious pulmonary tumor and tuberculosis on chest X-ray;
•3. Patients with measles, pertussis, influenza and other acute infectious diseases;
•4. Patients with acute upper respiratory tract infection, asthmatic bronchitis, bronchial asthma, bronchial foreign body and other respiratory diseases;
•5. Children with severe malnutrition and immunodeficiency;
•6. Patients with severe primary diseases such as heart, liver, kidney, digestive and hematopoietic system;
•7. Patients who have participated in or are participating in clinical trials of other drugs in the past three months;
•8. Patients with allergic constitution (allergic to more than 2 kinds of substances), or allergic to azithromycin, Qushi Tongluo formula and its components;
•9. Patients considered unsuitable by researchers.

发起方

Affiliated Hospital of Shandong University of Traditional Chinese Medicine